Treatment guidelines of metastatic colorectal cancer in older patients from the French Society of Geriatric Oncology (SoFOG)
- 1 May 2020
- journal article
- research article
- Published by Elsevier in Digestive and Liver Disease
- Vol. 52 (5) , 493-505
Abstract
No abstract availableKeywords
This publication has 89 references indexed in Scilit:
- Geriatric Factors Predict Chemotherapy Feasibility: Ancillary Results of FFCD 2001-02 Phase III Study in First-Line Chemotherapy for Metastatic Colorectal Cancer in Elderly PatientsJournal of Clinical Oncology, 2013
- First-Line Cetuximab Plus Capecitabine in Elderly Patients with Advanced Colorectal Cancer: Clinical Outcome and Subgroup Analysis According toKRASStatus from a Spanish TTD Group StudyThe Oncologist, 2012
- Cetuximab-based therapy in elderly comorbid patients with metastatic colorectal cancerBritish Journal of Cancer, 2012
- Comprehensive Geriatric Assessment in the Decision-Making Process in Elderly Patients With Cancer: ELCAPA StudyJournal of Clinical Oncology, 2011
- Chemotherapy options in elderly and frail patients with metastatic colorectal cancer (MRC FOCUS2): an open-label, randomised factorial trialThe Lancet, 2011
- FOLFOX4 in the treatment of metastatic colorectal cancer in elderly patients: A prospective studyArchives of Gerontology and Geriatrics, 2011
- EORTC elderly task force position paper: Approach to the older cancer patientEuropean Journal of Cancer, 2010
- Capecitabine in combination with oxaliplatin or irinotecan in elderly patients with advanced colorectal cancer: results of a randomized phase II studyAnnals of Oncology, 2009
- Comparing safety and efficacy of first‐line irinotecan/fluoropyrimidine combinations in elderly versus nonelderly patients with metastatic colorectal cancerCancer, 2009
- Use of the folinic acid/5-fluorouracil/irinotecan (FOLFIRI 1) regimen in elderly patients as a first-line treatment for metastatic colorectal cancer: a Phase II studyCancer Chemotherapy and Pharmacology, 2008